FDA Approved: BINOSTO — Supplemental Application (Radius Health, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for BINOSTO (alendronate sodium) to expand its label for the treatment of osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• BINOSTO (ALENDRONATE SODIUM)

Snippet

SUPPL AP for BINOSTO (ALENDRONATE SODIUM)